Patent Prosecution | Harness Dickey

Corroboration of the Inventor is Necessary, but Evaluated Under a Rule of Reason, Considering the Totality of the Circumstances

Response Arguments Do Not Have to Be Preemptively Addressed in the Petition or Institution Decision

Accused Trade Secret Thief Failed to Make Uber Showing Required for Writ of Mandamus

Claims Can’t Be Construed Contrary to Specification, and then Invalidated for Being Contrary to Specification

Foreign Suits Involving Foreign Patents Do Not Create a Case or Controversy in the U.S.

When Your Background Dooms The Invention

Objective Indicia Were Properly Considered and Did Not Save Cookie Package Patent from Summary Judgment of Obviousness

Mere Quantification of the Results of a Known Process is Not Patentable

Knowledge of Ex-Employees Working for Accused Infringer Makes Inducement Claim Plausible

At The Bench: 2017 Mid-Year Case Review

Follow-on IPR Petitions are Unfair to Patent Owners and an Inefficient Use of the Process

Federal Circuit’s Amicus Brief in Oil States

News Alert: Precedential Patent and Trademark Order by the Federal Circuit

Not Every Instance of an Agency Reaching Inconsistent Outcomes in Similar, Related Cases will Necessarily be Erroneous

“A Reasonable Adjudicator Would have Wanted to Review this Evidence.”

Preemption is “Part and Parcel” of the §101; But Lack of Preemption Does Not Necessarily Establish Patentability

Routine Optimization Cannot Make Invention Obvious Without A Reasonable Expectation for Success

A Foolish Consistency may be the Hobgoblin of Little Minds, but it is the Hallmark of a Successful Applicant/Patent Owner

You Can Ignore Claim Language As Long As it is Before the Colon

No man is an island, but Taiwan is, and so are Cabo Verde, Fiji, the Maldives, the Solomon Islands and Vanuatu

By:

Blog

ALL CATEGORIES

U.S. Chemical & Life Science Patents Q2 Newsletter

5 Federal Circuit Patent Cases You Need To Know

Enablement, Anticipation, and Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

Six Actions to Take to Ensure Your Trade Secret Stays Secret

Cannabis And Trademarks: Protecting Against Infringement

The Hypocrisy of ‘Delete IP’: Billionaire Frustrations Masquerading as Policy